Related Experiment Video
Updated: Mar 11, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
The Cost Effectiveness of LAA Exclusion
Bahij Kreidieh1, Moisés Rodríguez Mañero1, Sergio H Ibarra Cortez1
1Methodist DeBakey Heart and Vascular Center and Methodist Hospital Research Institute, The Methodist Hospital, Houston, Texas.
Insights
Left atrial appendage (LAA) exclusion offers stroke prevention comparable to anticoagulants with fewer bleeding risks. Cost-effectiveness analyses are crucial for optimizing healthcare resource allocation for these LAA exclusion strategies.
Area of Science:
- Cardiology
- Health Economics
- Medical Interventions
Background:
- Left atrial appendage (LAA) exclusion is a growing alternative to oral anticoagulants for stroke prevention.
- This method offers reduced bleeding risk and improved patient compliance.
- Limited healthcare funding necessitates economic evaluations of LAA exclusion.
Conclusions:
- LAA exclusion is an attractive alternative for stroke prevention.
- Cost-effectiveness studies are vital for guiding clinical and policy decisions.
- Optimizing resource allocation requires understanding the economic impact of LAA exclusion strategies.
Abstract:
Left atrial appendage (LAA) exclusion strategies are increasingly utilized for stroke prevention in lieu of oral anticoagulants. Reductions in bleeding risk and long-term compliance issues bundled with comparable stroke prevention benefits have made these interventions increasingly attractive. Unfortunately, healthcare funding remains limited. Comparative cost economic analyses are therefore critical in optimizing resource allocation. In this review we seek to discourse the cost economics analysis of LAA exclusion over available therapeutic alternatives (warfarin and the new oral anticoagulants (NOACs)). .
